global coronavirus diagnostics market size, share and forecast 2026 | techsci research
Post on 14-Jul-2021
3 Views
Preview:
DESCRIPTION
TRANSCRIPT
GLOBAL CORONAVIRUS DIAGNOSTICS MARKET
FORECAST & OPPORTUNITIES
2016 – 2026
MARKET INTELLIGENCE . CONSULTING
www.techsciresearch.com
2
Scope of ReportProduct of Interest (POI): Coronavirus Diagnostics
Review Period
2016 – 2019
Base Year
2020
Estimated Year
2021
Forecast Period
2022 – 2026
Year Range
Coronaviruses are a group of related RNA viruses that cause diseases in mammals andbirds. In humans and birds, they cause respiratory tract infections that can range frommild to lethal. Mild illnesses in humans include some cases of the common cold (which isalso caused by other viruses, predominantly rhinoviruses), while more lethal varieties cancause SARS, MERS, and COVID-19. In cows and pigs, they cause diarrhea, while in micethey cause hepatitis and encephalomyelitis.
Market Segmentation
REGION
• Europe
• North America
• South America
• Middle East & Africa
• Asia Pacific
FULL TEST TIME
• 1 Hours to 12 Hours
• Less Than 60 Minutes
• 13 Hours-24 Hours
• More Than 1 Days
END USER
• Hospitals
• Public Health Labs
• Private or Commercial Labs
• Physician Labs
• Others
USERS
• Multiple
• Single
TYPE OF TEST
• Molecular
• Serology
3
Table of Contents
S. No. Contents Page No.
1. Product Overview (Definition of product and major terminologies used in the report)
2. Research Methodology (Detailed description of the methodology used to conduct the research, Rawdata backup, list of all secondary sources, List of respondents for primary surveys)
3. Impact of COVID-19 on Global Coronavirus Diagnostics Market
4. Executive Summary (This chapter covers summary of the complete study.)
5.Voice of Customer (Brand Awareness, Challenges Faced Post Purchase, Factors Influencing Purchase Decision)
6.
Global Coronavirus Diagnostics Market Outlook, 2016-2026F (This chapter includes a brief overview of the product of interest market such as total market’s growth rate, expected growth rate, key growth levers, leading region, top grossing product Type of Tests, etc. It includes more of a qualitative information about the market.)
6.1. Market Size & Forecast
6.1.1. By Value (USD) & Volume (Units)
6.2. Market Share & Forecast
6.2.1. By Type of Test (Molecular v/s Serology)
6.2.2. By User (Multiple v/s Single)
6.2.3.By Full Test Time (1 Hours to 12 Hours, Less Than 60 Minutes, 13 Hours-24 Hours, More Than 1 Days)
6.2.4.By End User (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs, Others)
6.2.5. By Company (2020)
6.2.6.By Region (Asia-Pacific, Europe, North America, South America and Middle East & Africa)
6.3. Product Market Map
4
Table of Contents
S. No. Contents Page No.
7. Asia-Pacific Coronavirus Diagnostics Market Outlook, 2016-2026F
7.1. Market Size & Forecast
7.1.1. By Value (USD) & Volume (Units)
7.2. Market Share & Forecast
7.2.1. By Type of Test
7.2.2. By User
7.2.3. By Full Test Time
7.2.4. By End User
7.2.5. By Country
7.3. Asia-Pacific: Country Analysis
7.3.1. China Coronavirus Diagnostics Market Outlook, 2016-2026F
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value (USD) & Volume (Units)
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type of Test
7.3.1.2.2. By User
7.3.1.2.3. By Full Test Time
7.3.1.2.4. By End User
7.3.2. India Coronavirus Diagnostics Market Outlook, 2016-2026F
7.3.2.1. Market Size & Forecast
5
Table of Contents
S. No. Contents Page No.
7.3.2.1.1. By Value (USD) & Volume (Units)
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type of Test
7.3.2.2.2. By User
7.3.2.2.3. By Full Test Time
7.3.2.2.4. By End User
7.3.3. Japan Coronavirus Diagnostics Market Outlook, 2016-2026F
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value (USD) & Volume (Units)
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type of Test
7.3.3.2.2. By User
7.3.3.2.3. By Full Test Time
7.3.3.2.4. By End User
7.3.4. South Korea Coronavirus Diagnostics Market Outlook, 2016-2026F
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value (USD) & Volume (Units)
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type of Test
7.3.4.2.2. By User
7.3.4.2.3. By Full Test Time
7.3.4.2.4. By End User
6
Table of Contents
S. No. Contents Page No.
7.3.5. Australia Coronavirus Diagnostics Market Outlook, 2016-2026F
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value (USD) & Volume (Units)
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type of Test
7.3.5.2.2. By User
7.3.5.2.3. By Full Test Time
7.3.5.2.4. By End User
7.3.6. Singapore Coronavirus Diagnostics Market Outlook, 2016-2026F
7.3.6.1. Market Size & Forecast
7.3.6.1.1. By Value (USD) & Volume (Units)
7.3.6.2. Market Share & Forecast
7.3.6.2.1. By Type of Test
7.3.6.2.2. By User
7.3.6.2.3. By Full Test Time
7.3.6.2.4. By End User
7.3.7. Thailand Coronavirus Diagnostics Market Outlook, 2016-2026F
7.3.7.1. Market Size & Forecast
7.3.7.1.1. By Value (USD) & Volume (Units)
7.3.7.2. Market Share & Forecast
7.3.7.2.1. By Type of Test
7.3.7.2.2. By User
7.3.7.2.3. By Full Test Time
7.3.7.2.4. By End User
7
Table of Contents
S. No. Contents Page No.
8. Europe Coronavirus Diagnostics Market Outlook, 2016-2026F
8.1. Market Size & Forecast
8.1.1. By Value (USD) & Volume (Units)
8.2. Market Share & Forecast
8.2.1. By Type of Test
8.2.2. By User
8.2.3. By Full Test Time
8.2.4. By End User
8.2.5. By Country
8.3. Europe: Country Analysis
8.3.1. France Coronavirus Diagnostics Market Outlook, 2016-2026F
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value (USD) & Volume (Units)
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type of Test
8.3.1.2.2. By User
8.3.1.2.3. By Full Test Time
8.3.1.2.4. By End User
8.3.2. Germany Coronavirus Diagnostics Market Outlook, 2016-2026F
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value (USD) & Volume (Units)
8.3.2.2. Market Share & Forecast
8
Table of Contents
S. No. Contents Page No.
8.3.2.2.1. By Type of Test
8.3.2.2.2. By User
8.3.2.2.3. By Full Test Time
8.3.2.2.4. By End User
8.3.3. United Kingdom Coronavirus Diagnostics Market Outlook, 2016-2026F
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value (USD) & Volume (Units)
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type of Test
8.3.3.2.2. By User
8.3.3.2.3. By Full Test Time
8.3.3.2.4. By End User
8.3.4. Italy Coronavirus Diagnostics Market Outlook, 2016-2026F
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value (USD) & Volume (Units)
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type of Test
8.3.4.2.2. By User
8.3.4.2.3. By Full Test Time
8.3.4.2.4. By End User
9
Table of Contents
S. No. Contents Page No.
8.3.5. Spain Coronavirus Diagnostics Market Outlook, 2016-2026F
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value (USD) & Volume (Units)
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type of Test
8.3.5.2.2. By User
8.3.5.2.3. By Full Test Time
8.3.5.2.4. By End User
8.3.6. Russia Coronavirus Diagnostics Market Outlook, 2016-2026F
8.3.6.1. Market Size & Forecast
8.3.6.1.1. By Value (USD) & Volume (Units)
8.3.6.2. Market Share & Forecast
8.3.6.2.1. By Type of Test
8.3.6.2.2. By User
8.3.6.2.3. By Full Test Time
8.3.6.2.4. By End User
10
Table of Contents
S. No. Contents Page No.
9. North America Coronavirus Diagnostics Market Outlook, 2016-2026F
9.1. Market Size & Forecast
9.1.1. By Value (USD) & Volume (Units)
9.2. Market Share & Forecast
9.2.1. By Type of Test
9.2.2. By User
9.2.3. By Full Test Time
9.2.4. By End User
9.2.5. By Country (United States, Canada, Mexico)
9.3. North America: Country Analysis
9.3.1. United States Coronavirus Diagnostics Market Outlook, 2016-2026F
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value (USD) & Volume (Units)
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type of Test
9.3.1.2.2. By User
9.3.1.2.3. By Full Test Time
9.3.1.2.4. By End User
11
Table of Contents
S. No. Contents Page No.
9.3.2. Canada Coronavirus Diagnostics Market Outlook, 2016-2026F
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value (USD) & Volume (Units)
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type of Test
9.3.2.2.2. By User
9.3.2.2.3. By Full Test Time
9.3.2.2.4. By End User
9.3.3. Mexico Coronavirus Diagnostics Market Outlook, 2016-2026F
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value (USD) & Volume (Units)
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type of Test
9.3.3.2.2. By User
9.3.3.2.3. By Full Test Time
9.3.3.2.4. By End User
12
Table of Contents
S. No. Contents Page No.
10. South America Coronavirus Diagnostics Market Outlook, 2016-2026F
10.1. Market Size & Forecast
10.1.1. By Value (USD) & Volume (Units)
10.2. Market Share & Forecast
10.2.1. By Type of Test
10.2.2. By User
10.2.3. By Full Test Time
10.2.4. By End User
10.2.5. By Country (Brazil, Argentina, Colombia)
10.3. South America: Country Analysis
10.3.1. Brazil Coronavirus Diagnostics Market Outlook, 2016-2026F
10.3.1.1. Market Size & Forecast
10.3.1.1.1 By Value (USD) & Volume (Units)
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type of Test
10.3.1.2.2. By User
10.3.1.2.3. By Full Test Time
10.3.1.2.4. By End User
13
Table of Contents
S. No. Contents Page No.
10.3.2. Argentina Coronavirus Diagnostics Market Outlook, 2016-2026F
10.3.2.1. Market Size & Forecast
10.3.2.1.1 By Value (USD) & Volume (Units)
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type of Test
10.3.2.2.2. By User
10.3.2.2.3. By Full Test Time
10.3.2.2.4. By End User
10.3.3. Colombia Coronavirus Diagnostics Market Outlook, 2016-2026F
10.3.3.1. Market Size & Forecast
10.3.3.1.1 By Value (USD) & Volume (Units)
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type of Test
10.3.2.2.2. By User
10.3.2.2.3. By Full Test Time
10.3.2.2.4. By End User
14
Table of Contents
S. No. Contents Page No.
11. Middle East & Africa Coronavirus Diagnostics Market Outlook, 2016-2026F
11.1. Market Size & Forecast
11.1.1. By Value (USD) & Volume (Units)
11.2. Market Share & Forecast
11.2.1. By Type of Test
11.2.2. By User
11.2.3. By Full Test Time
11.2.4. By End User
11.2.5. By Country (South Africa, Saudi Arabia, UAE, Kuwait)
11.3. Middle East & Africa : Country Analysis
11.3.1. South Africa Coronavirus Diagnostics Market Outlook, 2016-2026F
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value (USD) & Volume (Units)
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Type of Test
11.3.1.2.2. By User
11.3.1.2.3. By Full Test Time
11.3.1.2.4. By End User
15
Table of Contents
S. No. Contents Page No.
11.3.2. Saudi Arabia Coronavirus Diagnostics Market Outlook, 2016-2026F
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value (USD) & Volume (Units)
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Type of Test
11.3.2.2.2. By User
11.3.2.2.3. By Full Test Time
11.3.2.2.4. By End User
11.3.3. UAE Coronavirus Diagnostics Market Outlook, 2016-2026F
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value (USD) & Volume (Units)
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Type of Test
11.3.3.2.2. By User
11.3.3.2.3. By Full Test Time
11.3.3.2.4. By End User
16
Table of Contents
S. No. Contents Page No.
11.3.4. Kuwait Coronavirus Diagnostics Market Outlook, 2016-2026F
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value (USD) & Volume (Units)
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Type of Test
11.3.4.2.2. By User
11.3.4.2.3. By Full Test Time
11.3.4.2.4. By End User
11.3.5. Iran Coronavirus Diagnostics Market Outlook, 2016-2026F
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value (USD) & Volume (Units)
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Type of Test
11.3.5.2.2. By User
11.3.5.2.3. By Full Test Time
11.3.5.2.4. By End User
17
Table of Contents
S. No. Contents Page No.
12. Market Dynamics (This chapter assesses the major demand drivers and restraints.)
12.1. Drivers
12.2. Challenges
13.Market Trends & Developments (This section captures recent trends pertaining to manufacturing or consumption, market movements in terms of points of production and consumption, advancements and development)
14. Competitive Landscape
14.1. Competition Outlook
14.2. Global Players Profiled (Leading Companies)
14.2.1. Company Details
14.2.2. Products & Services
14.2.3. Financials (As Reported)
14.2.4. Key Market Focus & Geographical Presence
14.2.5. Recent Developments
14.2.6. Key Management Personnel
15.Strategic Recommendations (Based on the findings of the report strategic recommendations on how to enter and expand market share)
16. About Us & Disclaimer
19
Research Methodology
✓ Identifying Key Opinion
Leaders
✓ Questionnaire Design
✓ In-depth Interviews
Data Collection
Developing List of Respondents
Formulating Questionnaire
Market Profiling
Data Validation
Data Analysis
In-depth secondary research was conducted to
determine top players in the global coronavirus
diagnostics market, overall market size and segmental
market size.
In order to conduct industry experts’
interviews, TechSci formulated a detailed
discussion guide.
List of industry players and industry
specialists was developed.
TechSci conducted interviews with
industry experts and industry players for data collection and
verification.
Data obtained as a result of primary and secondary research was
validated through rigorous
triangulation.
The data was scrutinized using MS-Excel, statistical
tools and internal proprietary database to obtain qualitative and
quantitative insights about the global coronavirus
diagnostics market.
Data Collection
Data Filter& Analysis
Research &Intelligence
ActionableInsights
BusinessSolution
Primary Research Desk Research Company Analysis
✓ Recent Developments
✓ Market Changing
Aspects/Dynamics
✓ Government Policies
✓ Conclusion
✓ Market Participants
✓ Key Strengths
✓ LinkedIn✓ TechSci Internal
Database
✓ Factiva✓ Hoovers
Paid Sources
✓ Company Websites✓ Company Annual
Reports✓ White Paper Study✓ Financial Reports✓ Investor
Presentations✓ Regulatory Body✓ Associations, etc.
Secondary Research
Primary Research
20
Research Methodology
Baseline Methodology
Our dedicated team of industry experts has monitored and analyzed various aspects of the global coronavirus diagnostics market. The
team has analyzed the outlook of various segments of this market, while considering the major influencing factors such as increase
coronavirus diagnostics. The study includes market forecasting, which would enable our clients to take better decisions while planning
their strategy to achieve sustainability in the global coronavirus diagnostics market.
Methodology Followed for Calculation of Market Size:
• Market Size by Value & Volume : Market size, in terms of value, for the year 2020 was calculated based on information collected
through exhaustive secondary research and primary surveys, with various key opinion leaders/stakeholders, such as coronavirus
diagnostics manufacturers, channel partners, market influencers & end users, industry experts, and other industry participants.
• The team interviewed more than 15 – 20 coronavirus diagnostics manufacturers, 100 – 120 end users, and 15 – 20 industry experts
and other value chain stakeholders in the global coronavirus diagnostics market to obtain the overall market size from 2016 to 2020,
which was validated by the Delphi technique. Taking standard deviation into consideration, the market size was averaged out, to
arrive at the market size data during 2016-2020.
21
Research Methodology
• Respondents were asked about the current and future market growth rates, market shares by type of test, by user, by full test time,
by end user, by company and by each region. Removing the outlier responses, the geometric mean of growth estimates and
provider wise revenue shares generated across various segments were considered, to arrive at the final revenue shares. Revenue
shares generated across various type were further triangulated from other stakeholders.
Methodology Followed for Calculation of Market Shares:
• Market shares by type of test, by user, by full test time, by end user, by company and by each region were calculated based on the
responses received through primary surveys with industry experts, in which the respondents were asked about the market shares
or revenue generated from various types of coronavirus diagnostics. The final shares were calculated by taking the geometric mean
of the responses gathered from key opinion leaders after eliminating the outliers.
Methodology Followed for Forecasting:
• TechSci Research performed periodical checks on data collected through the surveys with logic checks and analyzed the survey
results in SPSS/Tableau Software.
• Data triangulation techniques were applied to fill the gaps and to present a more meaningful picture of the market. To forecast
global coronavirus diagnostics market, TechSci Research used various forecast techniques such as:
✓ Moving Average
✓ Time Series Analysis
✓ Regression Analysis
✓ Econometric and Judgmental Analysis
22
Research Methodology
TechSci Research used its own forecast tool, which is based on the growth of various allied industries in respective regions. TechSci Research
also used the impact analysis during short, medium and long term period to estimate the demand and to reach accurate market numbers. It
should be noted that the figures compiled are only for the organized market including market share data. The currency used in the report is the
United States Dollar (USD), with the market size indicated in USD million.
Partial List of Companies Interviewed Key Secondary Sources
▪ Abbott Laboratories
▪ Altona Diagnostics GmbH
▪ BioMerieux SA
▪ Bio-Rad Laboratories, Inc.
▪ Danaher Corporation
▪ F.Hoffmann-La Roche Ltd
▪ GSK Biologicals SA
▪ Mylab Discovery Solutions Pvt. Ltd.
▪ Seegene Inc.
▪ Siemens AG
▪ Thermo Fisher Scientific Inc.
▪ PerkinElmer, Inc.
▪ Quest Diagnostics Inc.
▪ Hologic, Inc.
▪ Quidel Corporation
▪ World Bank
▪ International Monetary Fund (IMF)
▪ TechSci Research Proprietary Database &
Knowledge Repository
▪ Company Annual Reports
▪ Industry Magazines
▪ Industry Reports
▪ News Dailies
▪ Credible Paid Databases
23
Industry Brief
According to TechSci Research report, “Global Coronavirus Diagnostics Market By Type of Test (Molecular v/s Serology), By User (Multiple v/s Single),
By Full Test Time (1 Hour - 12 Hours, Less Than 60 Minutes, 13 Hours - 24 Hours, More Than 1 Day), By End User (Hospitals, Public Health Labs,
Private or Commercial Labs, Physician Labs, Others), By Region, Competition, Forecast & Opportunities, 2026”, the global coronavirus diagnostics
market is expected to reach USD15579.56 million by 2026 on account of increasing R&D activities related to coronavirus diagnostics and treatment by
major companies and research laboratories around the globe. Additionally, increasing funding & grants by various governments around the world to find
out efficient diagnostic and treatment methods is further expected to spur the market over the next few years. Furthermore, increasing healthcare
spending and rising need to protect the population from such outbreaks are expected to positively impact the growth of market in the coming years.
However, high cost of diagnostics can hamper the growth of market, especially in the developing economies in the near term. Additionally, limited
availability of diagnostic kits can hinder the growth of market.
The global coronavirus diagnostics market is segmented based on type of test, user, full test time, end user, company and region. Based on type of
test, the market can be bifurcated into molecular and serological tests. The serology tests segment is expected to witness significant growth during the
forecast period. Based on full test time, the market can be fragmented into less than 60 minutes, 1 hour to 12 hours, 13 hours - 24hours and more than
1 day. 1 hour to 12 hours segment is currently dominating the market is expected to do so in the forecast period as well as the methods that are
available right now take this much duration in the diagnosis of COVID-19 since they involve real time PCR test followed by gene fingerprinting which
usually takes time. The less than 60 minutes segment is also expected to witness significant growth during the forecast period because California-
based molecular diagnostics company Cepheid Inc., a subsidiary of Danaher Corporation, has developed a rapid coronavirus diagnostic test with
detection time of about 45 minutes and has got the approval from the United States Food and Drug Administration (FDA) also. Based on end user, the
market can be segmented into hospitals, public health labs, private or commercial labs, physician labs and others. The hospitals segment is currently
the dominating segment and is expected to continue to do in future as well owing to the presence of sophisticated diagnostic and treatment facilities in
the hospitals.
F. Hoffmann-La Roche Ltd, Abbott Laboratories, Danaher Corporation, Siemens AG, Thermo Fisher Scientific Inc., Mylab Discovery Solutions Pvt. Ltd.,
Bio-Rad Laboratories, Inc., BioMerieux SA, GSK Biologicals SA, Altona Diagnostics GmbH, Seegene Inc., PerkinElmer, Inc., Quest Diagnostics Inc.,
Hologic, Inc., Quidel Corporation are some of the leading players operating in the global coronavirus diagnostics market. The companies operating in
the market are increasingly focusing on developing low cost diagnostic kits that offer high efficiency and accuracy. For instance, recently Pune (India)
based molecular diagnostic company Mylab Discovery Solutions Pvt. Ltd. has become the first Indian company to have received the validation for its
COVID-19 diagnostic test kits also known as the Reverse Transcription Polymerase Chain Reaction (RT-PCR) tests by the Drug Controller of India,
after the National Institute of Virology validated its test.
“Europe and Asia Pacific are expected to dominate the coronavirus diagnostics market during the forecast period. Increasing investments in R&D
activities along with strong support from the governments in both the regions are further expected to create huge market opportunities for diagnostic
players over the next few years.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting
firm.
24
Sample Data - Snapshot
25%25%25%25%25%25%25%25%25%25%25%
25%25%25%25%25%25%25%25%25%25%25%
25%25%25%25%25%25%25%25%25%25%25%
25%25%25%25%25%25%25%25%25%25%25%
2016
2017
2018
2019
2020
2021E
2022F
2023F
2024F
2025F
2026F
1 Hours to 12 Hours Less Than 60 Minutes 13 Hours-24 Hours More Than 1 Days
Asia-Pacific Coronavirus Diagnostics Market Share, By Full Test Time, By Value, 2016–2026F
5.0
0
6.0
0
7.0
0
8.0
0
9.0
0
10
.00
11
.00
12
.00
13
.00
14
.00
15
.00
10.00 20.00 30.00 40.00 50.00 60.00 70.00 80.00 90.00 100.00 110.00
2016 2020 2021E 2026F
By Value (USD Million) By Volume (Units)
Global Coronavirus Diagnostics Market Size, By Value (USD Million) & By Volume (Units), 2016–2026F
20%20%20%20%20%20%20%20%20%20%20%
20%20%20%20%20%20%20%20%20%20%20%
20%20%20%20%20%20%20%20%20%20%20%
20%20%20%20%20%20%20%20%20%20%20%
20%20%20%20%20%20%20%20%20%20%20%
2016
2017
2018
2019
2020
2021E
2022F
2023F
2024F
2025F
2026F
Hospitals Public Health Labs Private or Commercial Labs Physician Labs Others
India Coronavirus Diagnostics Market Share, By End User, By Value, 2016–2026F
25
Report Ordering
Report Name: GLOBAL CORONAVIRUS DIAGNOSTICS MARKET
FORECAST & OPPORTUNITIES2016 – 2026
To View Sample OR Purchase Report
License Type Price
Single User License $4900
Multi-User License $5900
Custom Research License $8900
About Us & Disclaimer
TechSci Research is a global market research and consulting company with offices in the US, UK and India. TechSci Research provides market research reports in
number of areas to organizations. The company uses innovative business models that focus on improving productivity, while ensuring creation of high-quality reports. The
proprietary forecasting models use various analyses of both industry-specific and macroeconomic variables on a state-by-state basis to produce a unique ‘bottom-up’
model of a country, regional and global industry prospects. Combined with the detailed analysis of company activity and industry trends, the result is a uniquely rich
evaluation of the opportunities available in the market.
Related Reports
• Global Coronavirus Vaccine Market By Infection Type (HCoV-229E, HCoV-OC43, SARS-CoV, New Haven CoV, HKU1-CoV, MERS-CoV, SARS-CoV-2,
Others), By Vaccine Type (Inactivated Coronavirus Vaccine, Live Attenuated Coronavirus Vaccine, S-Protein Based Coronavirus Vaccine), By
Product Type (Monovalent Vaccine v/s Multivariant Vaccine), By Route of Administration (Oral, Intramuscular, Subcutaneous), By Patient
Type (Pediatric v/s Adult), By End User (Hospitals, Clinics, Research Institutes, Others), By Region, Forecast & Opportunities, 2026
• Global 3D Mobile C-Arm Market By Application (Orthopedics, Trauma, Cardiovascular, Urology, Gastroenterology, Neurology, Others) By End
Users (Hospitals, Specialty Clinics, Ambulatory Surgical Clinics) By Region, Competition Forecast & Opportunities, 2026.
The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is made that it is timely,accurate or complete. TechSci Research has taken due care and caution in compilation of data as this has been obtained from various sources including which it considersreliable and firsthand. However, TechSci Research does not guarantee the accuracy, adequacy or completeness of any information and it is not responsible for any errors oromissions or for the results obtained from the use of such information and especially states that it has no financial liability whatsoever to the subscribers / users of thisreport. The information herein, together with all estimates and forecasts, can change without notice. All the figures provided in this document are indicative of relative marketsize and are strictly for client’s internal consumption. Usage of the same for purpose other than internal will require prior approval of TechSci Research.
TechSci Research – North America708 Third Avenue, Manhattan,
New York, United StatesTel: +1- 646- 360- 1656
Email: sales@techsciresearch.com www.techsciresearch.com
Disclaimer
TechSci Research – Europe54, Old brook, Bretton,
Peterborough, United Kingdom
Email: sales@techsciresearch.com www.techsciresearch.com
TechSci Research – Asia-PacificB – 44, Sector – 57, Noida, National Capital
Region, U.P. - IndiaTel: +91-120-4523900
Email: sales@techsciresearch.com www.techsciresearch.com
top related